Difficulty: Medium
Average Score: 77%
Practice
Select the narcotic analgesic, which is an antagonist or partial mu receptor agonist:
Correct answer
B
Rationale
In this question, the correct answer is B) Pentazocine. Pentazocine is a mixed opioid agonist-antagonist, acting as a kappa receptor agonist and a weak mu receptor antagonist. This unique pharmacological profile makes it suitable for use in patients who may not respond well to pure mu receptor agonists due to its reduced potential for respiratory depression and abuse.
Option A) Fentanyl is a potent mu receptor agonist, used for severe pain but does not possess antagonist properties.
Option C) Codeine is a prodrug that is metabolized to morphine, a mu receptor agonist, making it unsuitable as an antagonist or partial agonist.
Option D) Methadone is a synthetic opioid that primarily acts as a mu receptor agonist, commonly used in opioid addiction treatment due to its long half-life and ability to prevent withdrawal symptoms.
In an educational context, understanding the pharmacological properties of different opioids is crucial for safe and effective pain management across the lifespan. Knowing which opioids act as agonists, antagonists, or partial agonists helps healthcare providers tailor treatment plans to individual patient needs, considering factors such as age, comorbidities, and risk of adverse effects. This knowledge also plays a critical role in preventing opioid misuse and optimizing therapeutic outcomes.
Option A) Fentanyl is a potent mu receptor agonist, used for severe pain but does not possess antagonist properties.
Option C) Codeine is a prodrug that is metabolized to morphine, a mu receptor agonist, making it unsuitable as an antagonist or partial agonist.
Option D) Methadone is a synthetic opioid that primarily acts as a mu receptor agonist, commonly used in opioid addiction treatment due to its long half-life and ability to prevent withdrawal symptoms.
In an educational context, understanding the pharmacological properties of different opioids is crucial for safe and effective pain management across the lifespan. Knowing which opioids act as agonists, antagonists, or partial agonists helps healthcare providers tailor treatment plans to individual patient needs, considering factors such as age, comorbidities, and risk of adverse effects. This knowledge also plays a critical role in preventing opioid misuse and optimizing therapeutic outcomes.